US FDA Should Regulate Ads Soliciting Mass Tort Suits, Group Says

Citing deaths and injuries caused when people stopped talking Xarelto in response to advertisements, US Chamber Institute for Legal Reform recommends Congress give FDA authority to halt misleading lawsuit ads.